Teniposide Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 50 mg/10 mL (5 mg/mL)

Reference Brands: Vumon.(US & EU)

Category: Oncology Cancer Care

Teniposide Injection is available in Injection and strengths such as 50 mg/10 mL (5 mg/mL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Teniposide Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Teniposide Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Teniposide Injection (Vumon) is a chemotherapy drug used in the treatment of acute lymphoblastic leukemia (ALL) and neuroblastoma. Available in the U.S. and EU, Teniposide is typically supplied as 50 mg/10 mL (5 mg/mL) for intravenous infusion. As a topoisomerase II inhibitor, it interferes with DNA replication in cancer cells, preventing their division. This injectable formulation is essential in multi-drug chemotherapy regimens and is administered under the supervision of healthcare professionals in clinical settings. It requires careful handling due to potential side effects, including bone marrow suppression and liver toxicity, making it suitable for B2B pharmaceutical distribution in oncology.